Updates are available Correction dated 2018-06-28
Click to view Correction: https://doi.org/10.1038/s41590-018-0140-0
-
Authors
- License Information
-
More Information
Article History
First Online: 16 November 2017
Competing interests
: V.A.B. holds patents on the PD-1 pathway licensed by Bristol-Myers Squibb, Roche, Merck, EMDSerono, Boehringer Ingelheim, AstraZeneca, Novartis and Dako.
